Stem cell eye treatment from your own cornea cells
Part of Eyes & vision clinical trials.
This trial tests an eye treatment made from your own cornea surface cells, grown in a lab and put back into the eye. It may help people with limbal stem cell deficiency by improving the health of the eye surface after a cell biopsy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have limbal stem cell deficiency in one or both eyes
- There is enough healthy tissue at the edge of your eye (limbus) so a small biopsy can be taken safely
- Your eye must be healthy enough for the biopsy without likely harm to the donor eye
- You are not pregnant
- You are not breast-feeding
- You have no known allergy to aprotinin (Trasylol) or sensitivity to bovine (cow) proteins
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a treatment that uses your own eye cells to repair the surface of the eye. It may help if you have severe damage to the clear front layer of your eye.
This study tests a new eye drop called CSB-001 for people with limbal stem cell deficiency (LSCD), a condition that damages the cornea. The goal is to see if the drops can help improve the health of the cornea and reduce inflammation.
This observational study follows patients with limbal stem cell deficiency (a condition affecting cells at the edge of the cornea that help maintain healthy eye surface) to understand how their vision changes over time. Researchers will track your eye health without giving you new treatment.
This trial tests a new way to repair the eye surface by using a thin sheet of cells from your own mouth, which are grown in the lab and then placed on your eye. It may help people whose eye damage hasn't improved with other treatments and who have very poor vision.
This study tests a new treatment that uses your own stem cells to repair a damaged cornea after a chemical burn. It may help reduce scarring and improve vision.
This trial tests an eye drop called BRM421 for people with mild to moderate limbal stem cell deficiency, a condition where the eye's surface doesn't heal properly. The goal is to see if this eye drop helps improve the eye's surface and reduce symptoms.
Hear when a new Limbal Stem Cell Deficiency trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.